19 results on '"Andrew Ilchyshyn"'
Search Results
2. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
- Author
-
John R. Ingram, H K Bell, Gudula Kirtschig, B Walker, Fiona Antony, M Walsh, Eva-B. Bröcker, Ingrid Salvary, J Wee, Emilia Duarte-Williamson, H Santander, Kathy Taghipour, David Gawkrodger, Enno Schmidt, Sam Gibbs, Alison M Layton, Michael Sticherling, J Adams, M Vatve, Joanne R Chalmers, Hywel C Williams, Fiona Craig, S Blackford, A Carmichael, Walter Bottomley, Adzura Azam, Chris Lovell, Karen E. Harman, Margaret Childs, Alexander Vincent Anstey, K. Hussain, Marinella Nik, C Günthert, A. Chapman, N. van Beek, Andrew M Wright, Rainer Hügel, C Barnard, Indre Verpetinske, K Davies, Thomas A. Luger, A Omerod, Karen Gibbon, Alex Waters, V Akhras, Robert Charles-Holmes, Shyamal Wahie, John C. English, James Mason, R.R. Coelho, Girish Khandubhai Patel, Robert Ellis, Jane C. Sterling, A Lloyd Lavery, Thomas R. Godec, Fenella Wojnarowska, Jane Ravenscroft, Richard Groves, H Malhomme, Kerstin Steinbrink, Andrew J. Nunn, Regine Gläser, Emma Veysey, Adam Ferguson, V Lewis, Diane Whitham, V Venning, M Westmoreland, G Wong, Chris Bower, N. Hepburn, C Thomas, P J Hampton, R. Wachsmuth, Andrew Ilchyshyn, Nick J. Levell, M G S Dunnill, S. Walton, and R Rallan
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pemphigoid ,medicine.medical_treatment ,Prednisolone ,RL ,Administration, Oral ,Equivalence Trials as Topic ,law.invention ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Germany ,Internal medicine ,Pemphigoid, Bullous ,medicine ,Initial treatment ,Humans ,skin and connective tissue diseases ,Glucocorticoids ,Aged ,Aged, 80 and over ,Doxycycline ,Medicine(all) ,Clinical Trials as Topic ,integumentary system ,business.industry ,Standard treatment ,General Medicine ,Articles ,Middle Aged ,medicine.disease ,R1 ,Dermatology ,United Kingdom ,Anti-Bacterial Agents ,Treatment Outcome ,030220 oncology & carcinogenesis ,Female ,Bullous pemphigoid ,business ,Adjuvant ,medicine.drug - Abstract
BACKGROUND: Bullous pemphigoid is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline gives acceptable short-term blister control while conferring long-term safety advantages over starting treatment with oral corticosteroids. METHODS: We did a pragmatic, multicentre, parallel-group randomised controlled trial of adults with bullous pemphigoid (three or more blisters at two or more sites and linear basement membrane IgG or C3). Participants were randomly assigned to doxycycline (200 mg per day) or prednisolone (0·5 mg/kg per day) using random permuted blocks of randomly varying size, and stratified by baseline severity (3-9, 10-30, and >30 blisters for mild, moderate, and severe disease, respectively). Localised adjuvant potent topical corticosteroids (
- Published
- 2017
3. 36. Recurrent strokes in younger patient with rash: a case of Sneddon’s syndrome
- Author
-
Himashi Anver, Tanya Potter, Andrew Short, Andrew Ilchyshyn, Shirish Dubey, and Siwalik Banerjee
- Subjects
medicine.medical_specialty ,b. Neurology in rheumatic diseases ,Rheumatology ,Recurrent stroke ,business.industry ,medicine ,B. CASE REPORTS ,Sneddon's syndrome ,medicine.symptom ,medicine.disease ,business ,Dermatology ,Rash - Published
- 2018
4. List of Contributors
- Author
-
Anthony Abdullah, Michael Abrouk, Tashmeeta Ahad, Imtiaz Ahmed, Anwar Al Hammadi, Caroline Allen, Amer Ali Almohssen, Wisam Alwan, Mahreen Ameen, Sadegh Amini, Bryan E. Anderson, Grant J. Anhalt, Donald J. Baker, Harini Rajgopal Bala, Julia Baltz, David Banach, Cedric C. Banfield, Robert Baran, Ajoy Bardhan, Melissa C. Barkham, Ysabel M. Bello, Emma Benton, Wilma F. Bergfeld, Eric Berkowitz, Brian Berman, Jeffrey D. Bernhard, Daniel Bernstein, John Berth-Jones, Chinmoy Bhate, Bhavnit K. Bhatia, Jonathan E. Blume, Nevianna Bordet, Catherine Borysiewicz, Gary J. Brauner, Robert T. Brodell, Marc D. Brown, Robert M. Burd, Anne E. Burdick, Niraj Butala, Jeffrey P. Callen, Ivan D. Camacho, Helena Camasmie, Daniel Caplivski, Mitchell S. Cappell, Genevieve A. Casey, Lawrence S. Chan, Loi-Yuen Chan, Jennifer K. Chen, Chen 'Mary' Chen, Nicole Yi Zhen Chiang, Anthony J. Chiaravalloti, Fiona J. Child, Anthony C. Chu, Timothy H. Clayton, Steven R. Cohen, Elizabeth A. Cooper, Susan M. Cooper, Nick Collier, Christina M. Correnti, Ian H. Coulson, M. Laurin Council, Shawn E. Cowper, Nicholas M. Craven, Daniel Creamer, Ponciano D. Cruz, Carrie Ann R. Cusack, Adam Daunton, Mark D.P. Davis, Robert S. Dawe, David P. D’Cruz, David de Berker, Danielle M. DeHoratius, Min Deng, Seemal R. Desai, Georgina Devlin, John J. DiGiovanna, Alexander Doctoroff, Roni P. Dodiuk-Gad, Dawn Z. Eichenfield, Lawrence F. Eichenfield, Drore Eisen, Ure Eke, Dirk M. Elston, Patrick O.M. Emanuel, Clinton W. Enos, Shaheen H. Ensanyat, Anna F. Falabella, Aaron S. Farberg, Lawrence S. Feigenbaum, Kristen Heins Fernandez, Nicole Fett, Andrew Y. Finlay, Bahar F. Firoz, Elnaz F. Firoz, James E. Fitzpatrick, Amy E. Flischel, Kelly A. Foley, Derek Freedman, Georgina A. Fremlin, Richard Fried, Philip Friedlander, Adam Friedman, Amy K. Forrestel, Brian S. Fuchs, Joanna E. Gach, Anjela Galan, Jaya Ganesh, Amit Garg, Lauren Geller, Carlo M. Gelmetti, Elizabeth Ghazi, Sneha Ghunawat, Leonard H. Goldberg, Mark J.D. Goodfield, Marsha L. Gordon, Asha Gowda, Daniel A. Grabell, Matthew Grant, Clive E.H. Grattan, Malcolm W. Greaves, Justin J. Green, Christopher E.M. Griffiths, Charles A. Gropper, Anna L. Grossberg, Aditya K. Gupta, Ali S. Hadi, Suhail M. Hadi, Iris A. Hagans, Bethany R. Hairston, Analisa Vincent Halpern, Caroline Halverstam, Natasha Harper, Matthew J. Harries, John Harris, Shannon Harrison, Michael M. Hatch, Adrian H.M. Heagerty, Adelaide A. Hebert, Stephen E. Helms, Camile L. Hexsel, Doris M. Hexsel, Warren R. Heymann, Elisabeth M. Higgins, Claire L. Higgins, Whitney A. High, Herbert Hönigsmann, Marcelo G. Horenstein, George J. Hruza, Andrea Hui, Ran Huo, Sally H. Ibbotson, Sherrif F. Ibrahim, Andrew Ilchyshyn, Dina Ismail, Stefania Jablonska, Heidi T. Jacobe, William D. James, Aysha Javed, Gregor B.E. Jemec, Graham A. Johnston, Stephen K. Jones, Jacqueline M. Junkins-Hopkins, Jessica Kaffenberger, Kelly R. Kane, Antonios Kanelleas, Ayşe Serap Karadağ, Laura Karas, Ruwani P. Katugampola, Bruce E. Katz, Roselyn Kellen, Murtaza Khan, Hooman Khorasani, Ellen J. Kim, Hee J. Kim, Brian Kirby, Joslyn S. Kirby, Rachel S. Klein, Kate Kleydman, Dimitra Koch, John J. Kohorst, John Y.M. Koo, Sandra A. Kopp, Neil J. Korman, Carrie Kovarik, Kenneth H. Kraemer, Bernice R. Krafchik, Karthik Krishnamurthy, Knut Kvernebo, Charlene Lam, Peter C. Lambert, James A.A. Langtry, Amir A. Larian, Cecilia A. Larocca, E. Frances Lawlor, Clifford M. Lawrence, Mark G. Lebwohl, Oscar Lebwohl, Julia S. Lehman, Tabi A. Leslie, Stuart R. Lessin, Jacob O. Levitt, Fiona M. Lewis, Maryam Liaqat, Kristina J. Liu, Michael P. Loosemore, Thomas A. Luger, Omar Lupi, Boris D. Lushniak, Calum C. Lyon, Andrea D. Maderal, Bassel H. Mahmoud, Slawomir Majewski, Richard B. Mallett, Steven M. Manders, Ranon Mann, Yasaman Mansouri, David J. Margolis, Orit Markowitz, Alexander Marsland, Agustin Martin-Clavijo, Daniela Martinez, Catalina Matiz, Marcus Maurer, Kevin McKerrow, Nekma Meah, Giuseppe Micali, Robert G. Micheletti, Leslie G. Millard, James E. Miller, Jillian W. Wong Millsop, Daniel Mimouni, Ginat W. Mirowski, Sultan A. Mirza, Sonja Molin, Adisbeth Morales-Burgos, Warwick L. Morison, Cato Mørk, Colin A. Morton, Richard J. Motley, Megan Mowbray, Eavan G. Muldoon, Anna E. Muncaster, George J. Murakawa, Jenny E. Murase, Michele E. Murdoch, Adam S. Nabatian, Mio Nakamura, Rajani Nalluri, Zeena Y. Nawas, Glen R. Needham, Glenn C. Newell, Julia Newton-Bishop, Adam V. Nguyen, Rosemary L. Nixon, Jack C. O’Brien, Stephanie Ogden, Suzanne M. Olbricht, Sally Jane O’Shea, Cindy E. Owen, Michael Pan, Lisa Pappas-Taffer, Jennifer L. Parish, Lawrence Charles Parish, Michael Payette, Gary L. Peck, Sandra Pena, Jarad Peranteau, Frederick A. Pereira, William Perkins, Clifford S. Perlis, Robert G. Phelps, Tania J. Phillips, Maureen B. Poh-Fitzpatrick, Miriam Keltz Pomeranz, Samantha R. Pop, Pierluigi Porcu, James B. Powell, Lori D. Prok, Tia M. Pyle, Surod Qazaz, Vikram Rajkomar, Rabia S. Rashid, Mehdi Rashighi, Ravi Ratnavel, Christie G. Regula, Michael Renzi, Jean Revuz, Rachel V. Reynolds, Elisabeth Richard, Gabriele Richard, Darrell S. Rigel, Wanda Sonia Robles, Megan Rogge, Alain H. Rook, Jamie R. Manning, Ted Rosen, Misha Rosenbach, David Rosenfeld, Christopher Rowland Payne, Adam I. Rubin, Courtney Rubin, Malcolm H.A. Rustin, Thomas Ruzicka, Sara Samimi, Lawrence A. Schachner, Noah Scheinfeld, Bethanee J. Schlosser, Rhonda E. Schnur, Robert A. Schwartz, Matthew J. Scorer, Bryan A. Selkin, Jamie Seymour, Christine M. Shaver, Christopher R. Shea, Neil H. Shear, Tang Ngee Shim, Hiroshi Shimizu, Julia Siegel, Elisha Singer, Maral Kibarian Skelsey, Chris Sladden, Michael Sladden, Janellen Smith, Joanne E. Smucker, Najwa Somani, Lacy L. Sommer, Mary Sommerlad, Christine Soon, Jennifer A. Sopkovich, Nicholas A. Soter, James M. Spencer, Richard C.D. Staughton, Jane C. Sterling, Cord Sunderkötter, Saleem M. Taibjee, Deborah Tamura, Eunice Tan, William Y-M. Tang, Lynsey Taylor, Bruce H. Thiers, Lucy J. Thomas, Cody R. Thornton, Anne-Marie Tobin, Rochelle R. Torgerson, Antonella Tosti, Fragkiski Tsatsou, Yukiko Tsuji-Abe, William F.G. Tucker, Stephen K. Tyring, Jeremy Udkoff, Robin H. Unger, Walter P. Unger, Sarah Utz, Martha C. Valbuena, Peter van de Kerkhof, Abby S. Van Voorhees, Ramya Vangipuram, David Veitch, Vanessa Venning, Sarah G. Versteeg, Martha Viera, Carmela C. Vittorio, Ruth Ann Vleugels, Gorav N. Wali, Joanna Wallengren, Joy Wan, Karolyn A. Wanat, Gabriele Weichert, Anja K. Weidmann, Jeffrey M. Weinberg, Victoria P. Werth, Lucile E. White, Adam H. Wiener, Jonathan K. Wilkin, Nathaniel K. Wilkin, Jason Williams, Niall Wilson, Karen Wiss, Joseph A. Witkowski, Lauren E. Wiznia, Henry K. Wong, Junie Li Chun Wong, Andrew L. Wright, Cooper C. Wriston, Benedict C. Wu, Adam Wulkan, Andrea L. Zaenglein, Irshad Zaki, Joshua A. Zeichner, Tian Hao Zhu, John J. Zone, Christos C. Zouboulis, and Torstein Zuberbeir
- Published
- 2018
- Full Text
- View/download PDF
5. Granuloma annulare
- Author
-
Andrew Ilchyshyn and Ajoy Bardhan
- Published
- 2018
- Full Text
- View/download PDF
6. Chronic tarsal conjunctivitis
- Author
-
Christina Leitner, Ian A. Cree, George T. Smith, Andrew Ilchyshyn, Nicholas Cook, and Fizza Mushtaq
- Subjects
Adult ,medicine.medical_specialty ,Allergy ,Adolescent ,Contact allergy ,medicine.medical_treatment ,Physical examination ,Cosmetics ,Diagnosis, Differential ,Lymphocytic Infiltrate ,Young Adult ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Epiphora ,medicine ,Humans ,Cosmetic ,Steroid ,Aged ,Conjunctivitis, Allergic ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Allergen ,General Medicine ,Middle Aged ,Conjunctivitis ,medicine.disease ,Dermatology ,Surgery ,Ophthalmology ,medicine.anatomical_structure ,Chronic Conjunctivitis ,Chronic Disease ,030221 ophthalmology & optometry ,Female ,Histopathology ,Eyelid ,Differential diagnosis ,business ,Research Article ,Topical steroid - Abstract
Background Toxicity is rarely considered in the differential diagnosis of conjunctivitis, but we present here a new form of toxic conjunctivitis with unusual clinical features. Between 2010 and 2013, a new clinical presentation of chronic conjunctivitis unresponsive to normal treatment was noted within a Primary Care Ophthalmology Service. Methods Retrospective review of case records and histopathology results. Results A total of 55 adult patients, all females, presented with epiphora and stickiness. They did not complain of itch and had had symptoms for an average of 9 months. Clinical examination showed bilateral moderate to severe upper and lower tarsal conjunctival papillary reaction, without corneal or eyelid changes and mild bulbar conjunctival hyperaemia in a third of cases. Biopsies were taken in 15 cases to exclude an atypical infection or lymphoma. Histologically, there was a variable superficial stromal lymphocytic infiltrate, involving the epithelium in more severe cases. The majority of the cells were CD3 positive T-lymphocytes and follicle formation was not noted. The clinical history in all cases included prolonged use of eye make- up and other facial cosmetic products. Clinical symptoms of epiphora settled with topical steroid drops, but the clinical signs of chronic tarsal inflammation persisted until withdrawal of the facial wipes thought to contain the inciting agent, though the exact nature of this remains unclear. Conclusion The presentation, appearances, histological features are consistent with a contact allergen-driven chronic conjunctivitis. Steroid treatment provided good relief of symptoms and patients were advised to avoid potential contact allergens. Management remains difficult. Further research into contact allergies of mucous membranes and identification of its allergens is required. Electronic supplementary material The online version of this article (doi:10.1186/s12886-016-0294-1) contains supplementary material, which is available to authorized users.
- Published
- 2016
- Full Text
- View/download PDF
7. Decline of dermatological publications in the UK: truth or myth?
- Author
-
A. Martin‐Clavijo, Andrew Ilchyshyn, and C. M. L. Roberts
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,Ophthalmology ,medicine ,Alternative medicine ,Dermatology ,business - Abstract
Summary Background. For some time, there has been a suspicion that the number of articles published by UK-based authors in dermatology has declined. This probably reflects a reduction in the publication output of dermatology departments generally. Methods. We identified articles with British authorship in the British Journal of Dermatology between 1970 and the present date, and compared the journal with the three most commonly cited dermatological journals: Archives of Dermatology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology. Later, we expanded this search to include a further 33 dermatological journals. Results. Despite an increase in the total number of published papers by the British Journal of Dermatology, there was a decline in the number of British-authored papers, from 97 (57%) in 1970 to 80 (22%) in 2005. The trend was also seen in the Journal of the American Academy of Dermatology, with 16 papers (5%) in 1989 and 7 (2%) in 2005. In Journal of Investigative Dermatology, British papers increased from 10 papers in 1975 to 17 in 2005, with a percentage decrease from 7% to 4%. Overall, despite an increase in the total number of publications in dermatological journals from 2745 in 1985–5034 in 2005, British publications increased from 271 in 1989 to only 289 in 2005, which represents a percentage decrease from 10% to 6%. Conclusions. Despite a three-fold increase in dermatology consultants and registrars in UK, a three-fold increase in dermatological journals and a four-fold increase in dermatological papers published, the overall number of British papers has remained static over the years.
- Published
- 2010
- Full Text
- View/download PDF
8. Total Hip Replacement in an Adolescent Patient with Harlequin Ichthyosis; A Case Report
- Author
-
Andrew Ilchyshyn, Kevin Ki-Wai Ho, James Beazley, and Pedro Foguet
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Arthroplasty, Replacement, Hip ,Health Status ,medicine.medical_treatment ,Total hip replacement ,Arthritis ,Oxford hip score ,Patient satisfaction ,Activities of Daily Living ,Humans ,Medicine ,Orthopedics and Sports Medicine ,business.industry ,Ichthyosis ,Recovery of Function ,Harlequin Ichthyosis ,medicine.disease ,Adolescent patient ,Arthroplasty ,Arthritis, Juvenile ,Surgery ,Treatment Outcome ,Patient Satisfaction ,Hip Joint ,business ,Ichthyosis, Lamellar - Abstract
Harlequin ichthyosis (HI) is a rare autosomal recessive skin disorder. No orthopaedic procedure has previously been described on a patient with HI. We report the case of a 17-year-old patient with HI who presented with bilateral juvenile idiopathic arthritis of the hips who underwent bilateral total hip replacements. Our standard operative and postoperative regime was followed and no complications occurred. One year after the second procedure our patient had a Oxford hip score of 43 and was very satisfied with the result.
- Published
- 2011
- Full Text
- View/download PDF
9. Proximal nail fold flap dissection for digital myxoid cysts - a seven year experience
- Author
-
Ure Eke, Imtiaz Ahmed, and Andrew Ilchyshyn
- Subjects
Aged, 80 and over ,Male ,medicine.medical_specialty ,business.industry ,Cysts ,Dermatology ,General Medicine ,Dissection (medical) ,Middle Aged ,medicine.disease ,Surgical Flaps ,Surgery ,Nail Diseases ,Text mining ,Treatment Outcome ,Recurrence ,Proximal nail fold ,Medicine ,Humans ,Female ,business ,Aged ,Retrospective Studies - Published
- 2014
10. Epidermolysis bullosa pruriginosa: a case with prominent histopathologic inflammation
- Author
-
Andrew Ilchyshyn, Richard A. Carr, Sivanie Vivehanantha, Saleem M. Taibjee, John A. McGrath, and Sharmila Madhogaria
- Subjects
Adult ,Pathology ,medicine.medical_specialty ,Collagen Type VII ,Inflammation ,Dermatology ,Biopsy ,medicine ,Missense mutation ,Humans ,Diagnostic Errors ,Direct fluorescent antibody ,medicine.diagnostic_test ,business.industry ,Epidermolysis bullosa dystrophica ,medicine.disease ,Epidermolysis Bullosa Dystrophica ,Disease Presentation ,Fluorescent Antibody Technique, Direct ,Mutation ,Female ,Epidermolysis bullosa ,Dermatopathology ,medicine.symptom ,business ,Epidermolysis Bullosa - Abstract
Importance Epidermolysis bullosa (EB) pruriginosa is a rare variant of dystrophic EB. It may manifest late in life and is characterized by intense pruritus, resulting in a phenotype resembling acquired inflammatory dermatoses. Dermatopathology textbooks include hereditary forms of EB among the “cell-poor” list of subepidermal blistering disorders. Observations We report a case of dominant dystrophic EB pruriginosa with late-onset cutaneous manifestations. A biopsy specimen showed subepidermal blistering with prominent inflammatory cells, including numerous eosinophils. Unfamiliarity with the distinctive clinicopathologic features of EB pruriginosa led to an initial erroneous histopathologic diagnosis of an acquired autoimmune blistering disorder. Direct immunofluorescence study results were negative for immune reactants. A strong clinical suspicion of hereditary EB pruriginosa led to mutation analysis of COL7A1, which confirmed a novel, heterozygous nonglycine missense mutation. Subsequently, 2 other family members who had nail dystrophy were also correctly diagnosed as having dominant dystrophic EB, highlighting the clinical spectrum of the disorder and the intrafamilial variability in disease presentation. Conclusions and Relevance The clinical features of EB pruriginosa are becoming more widely recognized, but dermatologists, dermatopathologists, and histopathologists should be aware that inflammatory infiltrates and late presentation are potential pitfalls in correctly diagnosing this subtype of hereditary EB.
- Published
- 2013
11. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis
- Author
-
Bernard V. North, Muy-Teck Teh, Celia Moss, Karen Stephens, Edel A. O'Toole, Aileen Taylor, Beverly A. Dale, Eli Sprecher, Helen Goodyear, H Unsworth, D. Paige, Bryan D. Young, Gianluca Tadini, Irene M. Leigh, Andrew Ilchyshyn, David P. Kelsell, Susan B. Mallory, Cameron T. C. Kennedy, Robin A.J. Eady, Thomas Cullup, Elizabeth E. Norgett, Philip Fleckman, John I. Harper, Virginia P. Sybert, David R. Witt, Charles A. Mein, and Patricia J.C. Dopping-Hepenstal
- Subjects
Molecular Sequence Data ,Lamellar granule ,Polymorphism, Single Nucleotide ,Frameshift mutation ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Congenital ichthyosis ,medicine ,Genetics ,Humans ,Genetics(clinical) ,ABCA12 ,Genetics (clinical) ,030304 developmental biology ,Oligonucleotide Array Sequence Analysis ,0303 health sciences ,biology ,Base Sequence ,Ichthyosis ,Infant, Newborn ,Chromosome Mapping ,Articles ,Harlequin Ichthyosis ,medicine.disease ,Disease gene identification ,3. Good health ,Chromosomes, Human, Pair 2 ,Chromosomal region ,Mutation ,biology.protein ,ATP-Binding Cassette Transporters ,Ichthyosis, Lamellar ,Microsatellite Repeats - Abstract
Harlequin ichthyosis (HI) is the most severe and frequently lethal form of recessive congenital ichthyosis. Although defects in lipid transport, protein phosphatase activity, and differentiation have been described, the genetic basis underlying the clinical and cellular phenotypes of HI has yet to be determined. By use of single-nucleotide–polymorphism chip technology and homozygosity mapping, a common region of homozygosity was observed in five patients with HI in the chromosomal region 2q35. Sequencing of the ABCA12 gene, which maps within the minimal region defined by homozygosity mapping, revealed disease-associated mutations, including large intragenic deletions and frameshift deletions in 11 of the 12 screened individuals with HI. Since HI epidermis displays abnormal lamellar granule formation, ABCA12 may play a critical role in the formation of lamellar granules and the discharge of lipids into the intercellular spaces, which would explain the epidermal barrier defect seen in this disorder. This finding paves the way for early prenatal diagnosis. In addition, functional studies of ABCA12 will lead to a better understanding of epidermal differentiation and barrier formation.
- Published
- 2005
12. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study
- Author
-
Azra Khan, Andrew Ilchyshyn, Camilo Diaz, and Chris J. O'callaghan
- Subjects
Adult ,Male ,medicine.medical_specialty ,Spirillaceae ,Enzyme-Linked Immunosorbent Assay ,Pilot Projects ,Dermatology ,Severity of Illness Index ,Helicobacter Infections ,Statistical significance ,medicine ,Odds Ratio ,Humans ,Urea ,Carbon Radioisotopes ,Breath test ,Clinical Trials as Topic ,biology ,medicine.diagnostic_test ,Helicobacter pylori ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Breath Tests ,Gastrointestinal disease ,Rosacea ,Gastritis ,Immunology ,Etiology ,Female ,medicine.symptom ,business - Abstract
Given the long purported anecdotal association between rosacea and gastrointestinal disease, the discovery that Helicobacter pylori causes gastritis and duodenal ulcer disease has led to a hypothesized role for this organism in the aetiology of rosacea. We conducted a case-series study of 49 patients to assess the potential association between severity of rosacea and direct and serological evidence of H. pylori infection. Patients were classified by severity into non-inflammatory erythematotelangiectatic or inflammatory/papulopustular rosacea and were tested for current H. pylori infection and evidence of previous exposure. Positive 13C-urea breath test and ELISA tests were more likely to be observed in patients with inflammatory rosacea, although not statistically significantly so (OR = 3.0, p = 0.15 and OR = 2.9, p = 0.16, respectively). However, the proportion of patients who tested positive in both assays (versus negative in at least one) was even higher in the inflammatory rosacea group and neared statistical significance (OR = 4.5, p = 0.06). This pilot study provides sufficient evidence suggestive of a positive association between the severity of rosacea and the presence of H. pylori to warrant further research.
- Published
- 2003
13. Glomus tumor as a cause of chronic low back pain: case report
- Author
-
Malobi I, Ogboli, Andrew, Ilchyshyn, R S, Walker, and D, Snead
- Subjects
Diagnosis, Differential ,Male ,Chronic Disease ,Humans ,Middle Aged ,Glomus Tumor ,Low Back Pain ,Intervertebral Disc Displacement - Abstract
A case of chronic low back pain caused by a glomus tumor that persisted more than 30 years is presented.To emphasize the need to consider skin tumors in the differential diagnosis of low back pain.Chronic low back pain can be caused by a myriad of factors. There are six relatively common skin tumors, which present as painful lesions. As seen in the reported case, if they occur in the lumbar region, they can cause low back pain.A subject with low back pain underwent an excision biopsy of a localized area of tenderness where his symptoms were reproduced when light pressure was applied.Histology confirmed that a glomus tumor accounted for the subject's pain.Painful skin tumors may cause low back pain and need to be considered in the differential diagnosis of chronic low back pain.
- Published
- 2003
14. Successful treatment of severe atopic dermatitis with methotrexate
- Author
-
Andrew Ilchyshyn and P. Balasubramaniam
- Subjects
medicine.medical_specialty ,business.industry ,Severe atopic dermatitis ,Medicine ,Methotrexate ,Dermatology ,business ,medicine.drug - Published
- 2005
- Full Text
- View/download PDF
15. Early Cyclosporine Treatment of Incipient Toxic Epidermal Necrolysis Induced by Concomitant Use of Lamotrigine and Sodium Valproate
- Author
-
Natasha Hashim, Andrew Ilchyshyn, Dalmianti Bandara, and Eunice Tan
- Subjects
medicine.medical_specialty ,Epidermis (botany) ,business.industry ,Dermatology ,General Medicine ,Disease ,Lamotrigine ,medicine.disease ,Toxic epidermal necrolysis ,Pharmacotherapy ,Concomitant ,medicine ,Stevens�Johnson syndrome ,business ,Partial thickness ,medicine.drug - Abstract
Sir, Adverse cutaneous reactions to drugs are among the most frequent complications of drug therapy. The most severe reaction is toxic epidermal necrolysis (TEN), a dermatological emergency with extensive epidermal necrosis resembling partial thickness burns and associated with high morbidity and mortality. StevensJohnson syndrome (SJS) and TEN constitute a spectrum of disease involving less than 10% and more than 30% epidermal detachment, respectively (1). Severe forms of SJS could evolve to TEN and the same drugs can induce both disorders (1). It is often impossible to distinguish between them at an early stage, since the final extent of detached epidermis is their distinguishing feature. We report here a case of incipient TEN induced by lamotrigine, where cyclosporine was used early in the course of the disease and appeared to halt its progression.
- Published
- 2003
- Full Text
- View/download PDF
16. Glomus Tumor as a Cause of Chronic Low Back Pain
- Author
-
R. S. Walker, David Snead, Malobi I. Ogboli, and Andrew Ilchyshyn
- Subjects
medicine.medical_specialty ,business.industry ,Background data ,equipment and supplies ,medicine.disease ,Excision biopsy ,Low back pain ,Chronic low back pain ,Glomus tumor ,Tenderness ,Lumbar ,health services administration ,medicine ,Orthopedics and Sports Medicine ,Neurology (clinical) ,Radiology ,Differential diagnosis ,medicine.symptom ,business ,human activities ,health care economics and organizations - Abstract
STUDY DESIGN A case of chronic low back pain caused by a glomus tumor that persisted more than 30 years is presented. OBJECTIVE To emphasize the need to consider skin tumors in the differential diagnosis of low back pain. SUMMARY OF BACKGROUND DATA Chronic low back pain can be caused by a myriad of factors. There are six relatively common skin tumors, which present as painful lesions. As seen in the reported case, if they occur in the lumbar region, they can cause low back pain. METHODS A subject with low back pain underwent an excision biopsy of a localized area of tenderness where his symptoms were reproduced when light pressure was applied. RESULTS Histology confirmed that a glomus tumor accounted for the subject's pain. CONCLUSIONS Painful skin tumors may cause low back pain and need to be considered in the differential diagnosis of chronic low back pain.
- Published
- 2003
- Full Text
- View/download PDF
17. Harlequin Ichthyosis
- Author
-
Andrew Ilchyshyn, Jemima E. Mellerio, Anders Vahlquist, Carol Chu, M. Glover, Maritta Hellström-Pigg, D. Paige, Mohamad Hassan Fouani, Celia Moss, Charles A. Mein, Diana Purvis, David P. Kelsell, Emma Hobson, Hülya Kayserili, John Harper, Shefali Rajpopat, Edel A. O'Toole, Giles G. Lestringant, David Everman, Cameron T. C. Kennedy, Nigel Burrows, Agneta Gånemo, Philip Fleckman, and Aileen Taylor
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Dermatology ,Gene mutation ,Compound heterozygosity ,Retinoids ,Young Adult ,Sepsis ,medicine ,Humans ,Skin Diseases, Infectious ,ABCA12 ,Young adult ,Child ,Retrospective Studies ,biology ,Ichthyosis ,business.industry ,Arthritis ,Infant ,Retrospective cohort study ,General Medicine ,Harlequin Ichthyosis ,Prognosis ,medicine.disease ,Failure to Thrive ,Respiratory failure ,Child, Preschool ,Chronic Disease ,Mutation ,biology.protein ,ATP-Binding Cassette Transporters ,Female ,Respiratory Insufficiency ,business ,Ichthyosis, Lamellar - Abstract
Objective: To assess the clinical outcomes of 45 cases of harlequin ichthyosis and review the underlying ABCA12 gene mutations in these patients. Design: Multicenter, retrospective, questionnaire-based survey. Setting: Dermatology research institute. Participants: Patients with harlequin ichthyosis for whom we had performed ABCA12 mutation analysis. Main Outcome Measures: Referring physicians were asked to complete a questionnaire using the patients' notes, detailing the clinical outcome of the affected child. In each case, the causative ABCA12 mutation was identified using standard polymerase chain reaction and sequencing techniques. Results: Of the 45 cases, the ages of the survivors ranged from 10 months to 25 years, with an overall survival rate of 56%. Death usually occurred in the first 3 months and was attributed to sepsis and/or respiratory failure in 75% of cases. The early introduction of oral retinoids may improve survival, since 83% of those treated survived, whereas 76% who were not given retinoids died. Recurrent skin infections in infancy affected one-third of patients. Problems maintaining weight affected 44%. Three children developed an inflammatory arthritis, and developmental delay was reported in 32%. Mutation analysis revealed that 52% of survivors had compound heterozygous mutations, whereas all deaths were associated with homozygous mutations. Conclusions: Harlequin ichthyosis should be regarded as a severe chronic disease that is not invariably fatal. With improved neonatal care and probably the early introduction of oral retinoids, the number of survivors is increasing. Compound heterozygotes appear to have a survival advantage.
- Published
- 2011
- Full Text
- View/download PDF
18. Cutaneous miliary pattern in metastasizing thin malignant melanoma
- Author
-
Joanna E. Gach, Andrew Ilchyshyn, David Snead, and Imtiaz Ahmed
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Medicine ,Dermatology ,business - Published
- 2004
- Full Text
- View/download PDF
19. Minerva: November 1999
- Author
-
Andrew Ilchyshyn and Imtiaz Ahmed
- Subjects
High rate ,North norway ,business.industry ,Life years gained ,medicine ,General Medicine ,Medical emergency ,Rural area ,medicine.disease ,business - Abstract
Women in Detroit can now get more than hot rollers and highlights at their weekly trip to the hair salon. In a campaign to cut high rates of hypertension, diabetes, and renal disease among the city's African-Americans, the National Kidney Foundation of Michigan is teaching stylists to spot suspicious symptoms and encourage their clients to see a doctor ( Detroit News , 9 September 1999). The scheme could go nationwide if it is successful, although it's still unclear how women will respond to being probed about their health while trapped under a hair dryer. The helicopter ambulance in Tromso, a rural area in north Norway, takes about 20 minutes to get airborne after an emergency call. Emergency medicine specialists estimate, however, that speeding up the take off would make little difference to the patients ( Prehospital Immediate Care 1999;3:136-9). An expert panel reviewed 65 cases over two years - 51 deaths and 14 survivors with ongoing problems - and concluded that shortening the response time by 15 minutes would have improved the outcome in only two patients; a 6% increase in life years gained across the board. Electroconvulsive therapy has …
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.